Tarsus Pharmaceuticals Stock Pattern Recognition Doji

TARS Stock

USD 67.96 -0.21 -0.31%

Use the pattern recognition workspace to apply Doji recognition and other studies to Tarsus Pharmaceuticals. The focus on pattern recognition signals tied to momentum and continuation helps organize trend, volatility, and risk context for Tarsus Pharmaceuticals.

Symbol

Recognition

The output start index for this execution was ten with a total number of output elements of fifty-one. The function generated a total of nine valid pattern recognition events for the selected time horizon. The Doji is candlestick pattern analysis indicator that fired when Tarsus Pharmaceuticals open and close prices are equal. It suggests that the direction of Tarsus Pharmaceuticals's trend maybe be nearing a turning point.

Tarsus Pharmaceuticals Technical Analysis Modules

Most technical analysis of Tarsus Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tarsus from various momentum indicators to cycle indicators. When you analyze Tarsus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

Tarsus Pharmaceuticals is scheduled to announce its earnings this week.Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California. Tarsus Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 46 people. As a large-cap equity, Tarsus Pharmaceuticals is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/B of 8.45, profit margin of -14.72%. Tarsus Pharmaceuticals has a market cap of 2.9 B, ROE of -23.39%.

Methodology

Unless otherwise specified, financial data for Tarsus Pharmaceuticals is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Tarsus (USA Stocks:TARS) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information presented is compiled from public filings and market reference sources and official institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Updates can be delayed depending on reporting conventions. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Tarsus Pharmaceuticals is covered by 8 analysts. 4 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Evercore ISI, Morgan Stanley, BMO Capital Markets, Oppenheimer & Co., Guggenheim Securities, HSBC Global Research, Raymond James, Bernstein Research, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Learn to be your own money manager

Tracking Tarsus Pharmaceuticals inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Bond Analysis Now

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.

All Next

Launch Module

Tarsus Pharmaceuticals pair trading

Pair trading with Tarsus Pharmaceuticals can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Tarsus Pharmaceuticals Pair Trading

Tarsus Pharmaceuticals Pair Trading Analysis

Identifying correlated replacements for Tarsus Pharmaceuticals is particularly important in concentrated portfolios where Tarsus Pharmaceuticals represents a large allocation. A poor substitute could introduce unintended factor or sector risks that persist beyond the required waiting period.

Correlation is not causation, but for Tarsus Pharmaceuticals it is a practical tool. High correlations between Tarsus Pharmaceuticals and a potential addition to the portfolio flag concentrated exposure, while low correlations signal diversification potential.

Correlation analysis and pair evaluation for Tarsus Pharmaceuticals can support hedging context. The method can be applied across sectors and broader equity sets.

Pair Correlation Correlation Matching

Additional Tools for Tarsus Stock Analysis

	Commodity Directory Find actively traded commodities issued by global exchanges
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC